Automated analysis of connected speech reveals early biomarkers of Parkinson's disease in patients with rapid eye movement sleep behaviour disorder
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
28144037
PubMed Central
PMC5428345
DOI
10.1038/s41598-017-00047-5
PII: 10.1038/s41598-017-00047-5
Knihovny.cz E-zdroje
- MeSH
- biologické markery MeSH
- dospělí MeSH
- dýchání MeSH
- dysfonie patofyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- Parkinsonova nemoc diagnóza patofyziologie MeSH
- porucha chování v REM spánku patofyziologie MeSH
- poruchy artikulace patofyziologie MeSH
- rozpoznávání automatizované metody MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- biologické markery MeSH
For generations, the evaluation of speech abnormalities in neurodegenerative disorders such as Parkinson's disease (PD) has been limited to perceptual tests or user-controlled laboratory analysis based upon rather small samples of human vocalizations. Our study introduces a fully automated method that yields significant features related to respiratory deficits, dysphonia, imprecise articulation and dysrhythmia from acoustic microphone data of natural connected speech for predicting early and distinctive patterns of neurodegeneration. We compared speech recordings of 50 subjects with rapid eye movement sleep behaviour disorder (RBD), 30 newly diagnosed, untreated PD patients and 50 healthy controls, and showed that subliminal parkinsonian speech deficits can be reliably captured even in RBD patients, which are at high risk of developing PD or other synucleinopathies. Thus, automated vocal analysis should soon be able to contribute to screening and diagnostic procedures for prodromal parkinsonian neurodegeneration in natural environments.
Zobrazit více v PubMed
Kent RD, Kent JF, Weismer G, Duffy JR. What dysarthrias can tell us about the neural control of speech. J. Phonetics. 2000;28:273–302. doi: 10.1006/jpho.2000.0122. DOI
Graber S, Hertrich I, Daum I, Spieker S, Ackermann H. Speech perception deficits in Parkinson’s disease: Underestimation of time intervals compromises identification of durational phonetic contrasts. Brain Lang. 2002;82:65–74. doi: 10.1016/S0093-934X(02)00002-0. PubMed DOI
Ho AK, Bradshaw J, Iansek R, Alfredson R. Speech volume regulation in Parkinson’s disease: Effects of implicit cues and explicit instructions. Neuropsychologia. 1999;37:1453–1460. doi: 10.1016/S0028-3932(99)00067-6. PubMed DOI
Ho AK, Iansek R, Marigliani C, Bradshaw JL, Gates S. Speech impairment in a large sample of patients with Parkinson’s disease. Behav. Neurol. 1998;11:131–137. doi: 10.1155/1999/327643. PubMed DOI
Duffy, J. R. Motor Speech Disorders: Substrates, Differential Diagnosis and Management, 3rd ed., Mosby, St. Louis (2013).
Rusz J, et al. Quantitative assessment of motor speech abnormalities in idiopathic REM sleep behaviour disorder. Sleep Med. 2016;19:141–147. doi: 10.1016/j.sleep.2015.07.030. PubMed DOI
Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY. How does Parkinsonism start? Prodromal Parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain. 2012;135:1860–1870. doi: 10.1093/brain/aws093. PubMed DOI
Schenck CH, et al. Rapid eye movement sleep behaviour disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy-a consensus statement from the International Rapid Eye Movement Sleep Behaviour Disorder Study Group. Sleep Med. 2013;14:795–806. doi: 10.1016/j.sleep.2013.02.016. PubMed DOI PMC
Postuma RB, et al. Identifying prodromal Parkinson’s disease: Pre‐Motor disorders in Parkinson’s disease. Mov. Disord. 2012;27:617–626. doi: 10.1002/mds.24996. PubMed DOI
Darley FL, Aronson AE, Brown JR. Differential diagnostic patterns of dysarthria. J. Speech Lang. Hear. Res. 1969;12:47–57. PubMed
Sussman JE, Tjaden K. Perceptual measures of speech from individuals with Parkinson’s disease and multiple sclerosis: Intelligibility and beyond. J. Speech Lang. Hear. Res. 2012;55:1208–1219. doi: 10.1044/1092-4388(2011/11-0048). PubMed DOI PMC
Skodda, S., Grönheit, W., Mancinelli, N. & Schlegel, U. Progression of voice and speech impairment in the course of Parkinson’s disease: a longitudinal study. Parkinsons Dis.389195 (2013). PubMed PMC
Little MA, McSharry PE, Hunter EJ, Spielman J, Ramig LO. Suitability of dysphonia measurement for telemonitoring of Parkinson’s disease. IEEE T. Biomed. Eng. 2009;56:1015–1022. doi: 10.1109/TBME.2008.2005954. PubMed DOI PMC
Novotný M, Rusz J, Čmejla R, Růžička E. Automatic evaluation of articulatory disorders in Parkinson’s disease. IEEE/ACM T. Audio Speech Lang. Proces. 2014;22:1366–1378. doi: 10.1109/TASLP.2014.2329734. DOI
Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson’s Disease Rating Scale: motor examination section. Mov. Disord. 1998;13:633–636. doi: 10.1002/mds.870130404. PubMed DOI
Boersma P. Praat, a system for doing phonetics by computer. Glot International. 2001;5:341–345.
Rosen K, et al. Automatic method of pause measurement for normal and dysarthric speech. Clin. Linguist. Phonet. 2010;24:141–154. doi: 10.3109/02699200903440983. PubMed DOI
International Telecommunication Union. Standardization Sector of ITU. ITU-T G.729, WTSC-96, Geneva, 1–39 (1996).
Rusz J, Čmejla R, Růžičková H, Růžička E. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson’s disease. J. Acoust. Soc. Am. 2011;129:350–367. doi: 10.1121/1.3514381. PubMed DOI
Postuma RB, Gagnon JF, Bertrand JA, Marchand DG, Montplaisir JY. Parkinson risk in idiopathic REM sleep behavior disorder Preparing for neuroprotective trials. Neurology. 2015;84:1104–1113. doi: 10.1212/WNL.0000000000001364. PubMed DOI PMC
Benecke J, Rothwell C, Dick PJR, Day PL, Marsden CD. Disturbance of sequential movements in patients with Parkinson’s disease. Brain. 1987;110:361–379. doi: 10.1093/brain/110.2.361. PubMed DOI
Spencer KA, Rogers MA. Speech motor programming in hypokinetic and ataxic dysarthria. Brain Lang. 2005;94:347–366. doi: 10.1016/j.bandl.2005.01.008. PubMed DOI
Hammen VL, Yorkston KM. Speech and pause characteristics following speech rate reduction in hypokinetic dysarthria. J. Commun. Disord. 1996;29:429–445. doi: 10.1016/0021-9924(95)00037-2. PubMed DOI
Weismer, G. & McNeil, M. Articulatory characteristics of Parkinsonian dysarthria: Segmental and phrase-level timing, spirantization, and glottal-supraglottal coordination. The dysarthrias: Physiology, acoustics, perception, management, College-Hill Press, San Diego 101–130 (1984).
Romenets SR, et al. Rapid eye movement sleep behavior disorder and subtypes of Parkinson’s disease. Mov. Disord. 2012;27:996–1003. doi: 10.1002/mds.25086. PubMed DOI
Gong Y, et al. Clinical manifestations of Parkinson disease and the onset of rapid eye movement sleep behavior disorder. Sleep Med. 2014;15:647–653. doi: 10.1016/j.sleep.2013.12.021. PubMed DOI
Sapir S. Multiple factors are involved in the dysarthria associated with Parkinson’s disease: a review with implications for clinical practice and research. J. Speech Lang. Hear. Res. 2014;57:1330–1343. doi: 10.1044/2014_JSLHR-S-13-0039. PubMed DOI
Levelt WJM. Speaking: From Intention to Articulation. A Bradford Book. Cambridge (Massachusetts)–London (England): The MIT Press; 1989. pp. 1–545.
Skodda S, Schlegel U. Speech rate and rhythm in Parkinson’s disease. Mov. Disord. 2008;23:985–992. doi: 10.1002/mds.21996. PubMed DOI
Ramus F, Nespor M, Mehler J. Correlates of linguistic rhythm in the speech signal. Cognition. 1999;73:265–292. doi: 10.1016/S0010-0277(99)00058-X. PubMed DOI
Hertrich I, Ackermann H. Gender-specific vocal dysfunctions in Parkinson’s disease: electroglottographic and acoustic analyses. Ann. Oto. Rhinol. Laryn. 1995;104:197–202. doi: 10.1177/000348949510400304. PubMed DOI
de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–535. doi: 10.1016/S1474-4422(06)70471-9. PubMed DOI
Trotti LM. REM sleep behaviour disorder in older individuals. Drugs Aging. 2010;27:457–470. doi: 10.2165/11536260-000000000-00000. PubMed DOI PMC
Rolinski M, et al. Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease. Brain. 2016;139:2224–2234. doi: 10.1093/brain/aww124. PubMed DOI PMC
Berg D, et al. MDS research criteria for prodromal Parkinson’s disease. Mov Disord. 2015;30:1600–1611. doi: 10.1002/mds.26431. PubMed DOI
Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods. 2007;39:175–191. doi: 10.3758/BF03193146. PubMed DOI
Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry. 1992;55:181–184. doi: 10.1136/jnnp.55.3.181. PubMed DOI PMC
American Academy of Sleep Medicine. International Classification of Sleep Disorders, Third Edition: Diagnostic and Coding Manual, Westchester, Illinois: American Academy of Sleep Medicine (2014).
Buskova, J., Ibarburu, V., Sonka, K. & Ruzicka, E. Screening for REM sleep behavior disorder in the general population. Sleep Med.24, 147 (2016). PubMed
Fischer E, Goberman AM. Voice onset time in Parkinson disease. J. Commun. Disord. 2010;43:21–34. doi: 10.1016/j.jcomdis.2009.07.004. PubMed DOI
Speech and gait abnormalities in motor subtypes of de-novo Parkinson's disease
Short-term effect of dopaminergic medication on speech in early-stage Parkinson's disease
Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson's disease
Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease
Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder
Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy